Published in Cell Biol Int Rep on April 01, 1982
C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol (1999) 7.15
Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med (1991) 2.93
Major outer membrane protein d of Escherichia coli K12. Purification and in vitro activity of bacteriophages k3 and f-pilus mediated conjugation. FEBS Lett (1977) 2.52
Monoclonal antibody PAL-E specific for endothelium. Lab Invest (1985) 2.37
Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol (1995) 2.33
The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects. Diabetologia (2000) 2.14
Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods (1993) 2.08
Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation (1990) 2.07
Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol (1997) 2.03
meoA is the structural gene for outer membrane protein c of Escherichia coli K12. Mol Gen Genet (1979) 1.70
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol (2005) 1.70
Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia (1999) 1.67
Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med (1986) 1.64
von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.57
Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol (1998) 1.54
Treatment of eczema herpeticum with acyclovir. Arch Dermatol (1983) 1.52
Relation between smoking and skin cancer. J Clin Oncol (2001) 1.50
The determination of lipids and proteins in suction blister fluid. J Invest Dermatol (1979) 1.46
On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients. J Invest Dermatol (1991) 1.44
Role of endothelial cells and their products in the modification of low-density lipoproteins. Biochim Biophys Acta (1986) 1.40
Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet (2001) 1.39
[Pruritus in systemic diseases; pathogenesis and treatment]. Ned Tijdschr Geneeskd (1994) 1.39
Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol (1994) 1.39
Effects of monocytopenia and anticoagulation in experimental Streptococcus sanguis endocarditis. Br J Exp Pathol (1980) 1.36
High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol (1995) 1.35
Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood (1988) 1.34
Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood (1985) 1.33
Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells. Biochem Biophys Res Commun (1983) 1.32
Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int (1984) 1.32
Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes (2000) 1.27
Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb (1991) 1.26
Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem (1990) 1.24
A common restriction fragment length polymorphism of the human apolipoprotein E gene and its relationship to type III hyperlipidaemia. Hum Genet (1987) 1.21
The missense mutation G12D in connexin30.3 can cause both erythrokeratodermia variabilis of Mendes da Costa and progressive symmetric erythrokeratodermia of Gottron. Am J Med Genet A (2009) 1.21
Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol (1994) 1.17
Rheumatoid arthritis--the clinical significance of histo- and immunopathological abnormalities in normal skin. J Rheumatol (1984) 1.17
The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet (2001) 1.16
Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertil Steril (2000) 1.15
Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol (1995) 1.13
The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome--an analysis by structural equation modelling. Int J Obes Relat Metab Disord (2002) 1.13
The metabolism in vitro of human low-density lipoprotein by the human hepatoma cell line Hep G2. Biochem J (1983) 1.12
Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler Thromb Vasc Biol (1997) 1.11
Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium. Biochim Biophys Acta (1984) 1.11
Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage. Circulation (1999) 1.09
Isolation and characterization of Escherichia coli K-12 F- mutants defective in conjugation with an I-type donor. J Bacteriol (1977) 1.08
Regulation of endothelial cell t-PA synthesis and release. Int J Hematol (1994) 1.08
Genetic analysis of sex and generation differences in plasma lipid, lipoprotein, and apolipoprotein levels in adolescent twins and their parents. Genet Epidemiol (1996) 1.08
Diltiazem-associated exfoliative dermatitis in a patient with psoriasis. Acta Derm Venereol (1986) 1.06
Simvastatin improves disturbed endothelial barrier function. Circulation (2000) 1.06
Heterogeneity of cells isolated from rat liver by pronase digestion: ultrastructure, cytochemistry and cell culture. J Reticuloendothel Soc (1976) 1.05
Binding of LP(a) to the low density lipoprotein receptor of human fibroblasts. FEBS Lett (1981) 1.04
Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study. Atherosclerosis (1999) 1.04
Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol (2000) 1.04
Randomized trial comparing cryopreserved cultured epidermal allografts with hydrocolloid dressings in healing chronic venous ulcers. J Am Acad Dermatol (1993) 1.03
Hepatic clearance of tissue-type plasminogen activator in rats. Thromb Haemost (1985) 1.02
Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood (1995) 1.01
Metabolomics (liver and blood profiling) in a mouse model in response to fasting: a study of hepatic steatosis. Biochim Biophys Acta (2007) 1.01
Apolipoprotein gene cluster on chromosome 19. Definite localization of the APOC2 gene and the polymorphic Hpa I site associated with type III hyperlipoproteinemia. Hum Genet (1988) 1.01
Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid (2001) 1.01
Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins. Arteriosclerosis (1984) 0.98
Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum Genet (1988) 0.98
Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Hum Genet (1986) 0.98
A case of growth retardation and cushing's syndrome due to excessive application of betamethasone-17-valerate ointment. Dermatologica (1974) 0.98
Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration. Arterioscler Thromb Vasc Biol (1998) 0.95
Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol (1995) 0.95
Immunoenzyme histochemical localization of fibrin degradation products in tissues. Am J Pathol (1981) 0.95
Cultured human skin fibroblasts and keratinocytes: differences in the regulation of cholesterol synthesis. J Invest Dermatol (1983) 0.95
Fumaric acid therapy for psoriasis: a randomized, double-blind, placebo-controlled study. J Am Acad Dermatol (1990) 0.95
The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. Thromb Haemost (1998) 0.95
Low density lipoprotein receptor expression on keratinocytes in normal and psoriatic epidermis. J Invest Dermatol (1987) 0.94
Role of the contact system in fibrinolysis. Semin Thromb Hemost (1987) 0.94
Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin. Biochem Biophys Res Commun (1989) 0.93
Perfused rat hindlegs. A model to study plasminogen activator release. Thromb Res (1983) 0.93
Hygiene, skin infections and types of water supply in Venda, South Africa. Trans R Soc Trop Med Hyg (1992) 0.92
IgE deposition in normal skin of patients with rheumatoid arthritis in relation to clinical and laboratory findings. Ann Rheum Dis (1985) 0.92
Immunoelectronmicroscopical investigations on the adsorptive endocytosis of low density lipoproteins by human fibroblasts. Exp Cell Res (1980) 0.92
In vivo catabolism of biologically modified LDL. Arteriosclerosis (1984) 0.92
Effect of ketoconazole on cholesterol synthesis and on HMG-CoA reductase and LDL-receptor activities in Hep G2 cells. Biochem Pharmacol (1987) 0.92
Total body exposure to ultraviolet radiation does not influence plasma levels of immunoreactive beta-endorphin in man. Photodermatol Photoimmunol Photomed (2001) 0.92
Genetic linkage between the collagen VII (COL7A1) gene and the autosomal dominant form of dystrophic epidermolysis bullosa in two Dutch kindreds. J Invest Dermatol (1992) 0.92
Clearance of the heavy and light polypeptide chains of human tissue-type plasminogen activator in rats. Biochem J (1986) 0.92
Immunoelectron microscopic visualization of the transcytosis of low density lipoproteins in perfused rat arteries. Eur J Cell Biol (1989) 0.91
The immunoglobulin-bearing cells in the lamina propria and the clinical response to a gluten-free diet in dermatitis herpetiformis. Arch Dermatol Res (1977) 0.91
Organization of experimentally induced arterial thrombosis in rats: the first six days. Artery (1982) 0.91
Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J Lipid Res (1998) 0.90
Effects of tissue-type plasminogen activator (t-PA) on Streptococcus sanguis-infected endocardial vegetations in vitro. J Antimicrob Chemother (1988) 0.90
The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation (2000) 0.90
von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII). Thromb Haemost (1998) 0.90
Inference of the strength of genotype-disease association from studies comparing offspring with and without parental history of disease. Ann Hum Genet (1993) 0.89
Adenosine 3':5'-cyclic monophosphate induces regulated secretion of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells. Thromb Haemost (1998) 0.89
Visualization of the interaction of native and modified low density lipoproteins with isolated rat liver cells. Eur J Cell Biol (1985) 0.89
Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease. Arterioscler Thromb Vasc Biol (1995) 0.89
Purification and properties of rat alpha 2 acute-phase macroglobulin. Biochim Biophys Acta (1979) 0.89